The MEF PKCe KO Cell Line is useful for studying the role of PKCe in various biological processes. Clonal MEFs have been derived from PKCepsilon knock-out embryos and subsequently stably transfected with empty pcDNA3 CMV/IE hygo+.
| Inventor | Institute |
|---|---|
| Peter Parker | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| SKU: | 151665 |
|---|---|
| Product description: | The MEF PKCe KO Cell Line is useful for studying the role of PKCe in various biological processes. Clonal MEFs have been derived from PKCepsilon knock-out embryos and subsequently stably transfected with empty pcDNA3 CMV/IE hygo+. Matched isogenic cell line with PKCe re-expressed is also available. Cells have reduced migratory capacity compared to their PKCe-expressing counterparts. Cells were used to demonstrate a role for PKCe in controlling the traffic of beta1 integrins in motile cells |
| Production details: | MEFs were derived from PKCe knockout embryos. Polyclonal PKCeKO cells were transfected with pcDNA3 CMV/IE hygro+ vector using calcium phosphate. Clonal stable cell lines were selected using limiting dilution. |
| Cellosaurus ID: | CVCL_AS81 |
| Disease: | Cancer |
| Cat. #: | 151665 |
|---|---|
| Provenance and Ownership: | The MEF PKCe KO Cell Line is owned by Cancer Research UK. CancerTools supplies the MEF PKCe KO Cell Line under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing MEF PKCe KO Cell Line directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Unit size: | 1×10^6 cells / vial |
| Organism: | Mouse |
| Tissue: | Embryo |
| Model: | Knock-Out |
| Format: | Frozen |
|---|---|
| Shipping conditions: | Dry ice |
| Growth medium: | Cells were selected, and are routinely cultured in DMEM + 10% FCS and 100ug/ml hygromycin at 30degC in a 10% CO2 atmosphere |
| References: |
Cited by 24 subsequent publications including: Ivaska, J. et al. 2002. EMBO J. 21:3608-19.PMID: 12110574 Kermorgant, S. et al. 2004. EMBO J. 23: 3721:34. PMID 15385963 Pardo et al. 2006. EMBO J. 25(13):3078-88. PMID: 16810323. FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.